Skip to content

Clinical trials

Completed Myelodysplastic Syndromes trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Status: Completed Country / region: Russia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20091
20101
20112
20142
20161
20172
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
St. Petersburg State Pavlov Medical University2
Celgene1
Celgene Corporation1
Federal Research Institute of Pediatric Hematology, Oncology and Immunology1
Ivan S Moiseev1
Janssen Research & Development, LLC1
Janssen-Cilag International NV1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes13
Leukemia, Myeloid, Acute5
Myeloproliferative Disorders4
Graft vs Host Disease2
Iron Overload2
Leukemia2
Lymphoma2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Thalassemia2
Anemia1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.